WebAs of Tuesday, April 11, Shockwave Medical Inc’s SWAV share price has surged by 10.64%, which has investors questioning if this is right time to sell.
Shockwave Medical, Inc. (NASDAQ:SWAV) Shares Sold by Dupont …
Web13 Apr 2024 · Shares of NASDAQ SWAV opened at $248.59 on Thursday. Shockwave Medical, Inc. has a 1-year low of $113.36 and a 1-year high of $320.54. The company has a debt-to-equity ratio of 0.05, a current ratio of 7.25 and a quick ratio of 6.06. The business's fifty day moving average price is $201.91 and its two-hundred day moving average price is … Web7 Mar 2024 · Founded. 2009. Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease … territorial army recruitment process
Shockwave to pay $100M for Neovasc, adding refractory angina …
Web12 Apr 2024 · SWAV Stock Overview. ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in … Web18 Jan 2024 · Shockwave Medical said it agreed to buy Neovasc for about $100 million to gain control of an investigational minimally invasive treatment for refractory angina. The device, Reducer, is an adjunctive therapy to treatments of coronary heart disease that is implanted to redistribute blood to ischemic areas of the heart. WebSWAV Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Shockwave Medical in the last 3 months. The average price target is $244.67 … territorial bank of american samoa login